Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

As we move forward, I am excited at the prospects that our company will blossom to a more mature company (going from its infancy to a true player in the biotech space). Jason Napodano has built a reasonable argument that once our PPS gets adequate funding; you just might see a paradigm shift in how Wall street values the company (obviously, it would get more fairly valued...which Jason has insuated that $.25 was a closer to or near a proper valuation). Certainly, it wont happen overnight...but as strong or positive news is released...it will build credibility with the Street and things will progress our stock price higher (over time).

What remains to be seen is if Gerald can avoid the nasty R/S (which is by far my worst fear). I hope that the MANF Orphan data and a new update on the LymPro program will become available within a week or two). Overall, the sentiment has gotten really bad here; but I believe the true bonus is any sign that funding has been secured and the capability to fund operations (up through a possible Lympro commercialization) does exist. GLTA!!!